Stimuli-Responsive Poly(Aspartamide) Derivatives and Their Applications As Drug Carriers
Total Page:16
File Type:pdf, Size:1020Kb
International Journal of Molecular Sciences Review Stimuli-Responsive Poly(aspartamide) Derivatives and Their Applications as Drug Carriers Guangyan Zhang 1,2,* , Hui Yi 1 and Chenhui Bao 1 1 School of Materials and Chemical Engineering, Hubei University of Technology, Wuhan 430068, China; [email protected] (H.Y.); [email protected] (C.B.) 2 Hubei Provincial Key Laboratory of Green Materials for Light Industry, Hubei University of Technology, Wuhan 430068, China * Correspondence: [email protected] Abstract: Poly(aspartamide) derivatives, one kind of amino acid-based polymers with excellent biocompatibility and biodegradability, meet the key requirements for application in various areas of biomedicine. Poly(aspartamide) derivatives with stimuli-responsiveness can usually respond to external stimuli to change their chemical or physical properties. Using external stimuli such as tem- perature and pH as switches, these smart poly(aspartamide) derivatives can be used for convenient drug loading and controlled release. Here, we review the synthesis strategies for preparing these stimuli-responsive poly(aspartamide) derivatives and the latest developments in their applications as drug carriers. Keywords: poly(aspartamide) derivatives; stimuli-responsive; drug carrier; nanoparticles; hydrogel; polymer-drug conjugate; drug-loading; controlled drug release Citation: Zhang, G.; Yi, H.; Bao, C. Stimuli-Responsive Poly(aspartamide) Derivatives and 1. Introduction Their Applications as Drug Carriers. Though the carbon-carbon backbone is conducive to the stability of polymers, it also Int. J. Mol. Sci. 2021, 22, 8817. limits the applications of these polymers in biomedical fields due to its low biocompat- http://doi.org/10.3390/ijms22168817 ibility and non-biodegradability. In the past decades, the interest in amino acid-based biodegradable polymers has increased significantly in biomedicine due to their good Academic Editors: Ádám Juhász and biocompatibility, biodegradability and non-toxicity of their degradation products. For Edit Csapó example, poly(glutamic acid) (PGA) and PGA-based polymers have been widely applied for controlled release of peptide, protein and anti-tumor drugs [1]; polylysine (PLL) and Received: 29 July 2021 its derivatives have been extensively investigated in gene delivery systems [2]. Moreover, Accepted: 13 August 2021 Published: 16 August 2021 other amino-acid containing degradable polymers have also been studied in tissue engineer- ing and biomedical imaging (e.g., magnetic resonance imaging and fluorescence imaging). Poly(aspartic acid)-based polymers, whose backbone is composed of aspartic acid, are Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in one of the most intensively studied amino acid-based polymers in drug [3,4]/gene [5–7] de- published maps and institutional affil- livery systems and other biomedical applications [8] due to their simple synthesis method, iations. excellent biocompatibility and biodegradability. The synthetic strategies of poly(aspartic acid)-based polymers mainly include the aminolysis reaction of poly(succinimide) (PSI) (Figure1a) and the ring-opening polymerization (ROP) of benzyl- L-aspartate N-carboxyanhydride (BLA-NCA) (Figure1b). For side chain-modified poly(aspartic acid)- based polymers, they can generally be prepared by the aminolysis reaction of PSI. For Copyright: © 2021 by the authors. example, a side chain-modified poly(aspartamide) (PASPAm) derivative, α,β-poly(N- Licensee MDPI, Basel, Switzerland. D L This article is an open access article 2-hydroxyethyl)- , -aspartamide (PHEA), can be obtained by the aminolysis reaction distributed under the terms and between ethanolamine and PSI, and has been further modified and intensively studied as conditions of the Creative Commons scaffolds [9], siRNA delivery systems [10,11] and drug carriers (e.g., hydrogel, nanoparti- Attribution (CC BY) license (https:// cles) [12–16]. For the block copolymers containing poly(aspartic acid)-based segment, they creativecommons.org/licenses/by/ usually can be synthesized by ROP of BLA-NCA. For instance, NK105 polymer, which is 4.0/). Int. J. Mol. Sci. 2021, 22, 8817. https://doi.org/10.3390/ijms22168817 https://www.mdpi.com/journal/ijms Int. J. Mol. Sci. 2021, 22, x FOR PEER REVIEW 2 of 18 block as the hydrophobic segment in which 50% carboxylic groups of PASPAm were re- acted with 4-phenyl-1-butanol by esterification reaction [17,18], has been used as delivery system in a paclitaxel-incorporating micellar nanoparticle anti-cancer formulation (NK105) that was approved for clinical trials (phase III) [19,20]. Besides NK105, poly(aspartic acid)- Int. J. Mol. Sci. 2021, 22, 8817 based polymers were also applied in two other formulations, NK911 [21] and NC2-6300 of 18 [22,23]. Among the above three clinical formulations, NC-6300 that is an epirubicin (EPI) conjugated PEG-block-PASPAm derived copolymer containing acid-labile hydrazone link- composedages, is the ofonly a poly(ethyleneone with stimuli glycol)-responsiveness. (PEG) block Results as the showed hydrophilic that NC segment-6300 exhibited and modi- a fiedstronger poly(aspartic anti-tumor acid)-based effect and block lower as cardioto the hydrophobicxicity compared segment to in free which EPI, 50% which carboxylic may be groupsdue to its of pH PASPAm responsiveness. were reacted with 4-phenyl-1-butanol by esterification reaction [17,18], has beenBecause used stimuli as delivery-responsive system polymers in a paclitaxel-incorporating can respond to the micellarchanges nanoparticleof environmental anti- cancerfactors formulation(e.g., pH, temperature) (NK105) that by was self approved-changing for either clinical their trials physical (phase properties III) [19,20,]. chemical Besides NK105,structures poly(aspartic, or both, they acid)-based exhibit attractive polymers prospects were also in applieda variety in of two fields other such formulations, as sensors, NK911energy conversion [21] and NC-6300 and drug/gene [22,23]. Amongdelivery thesystems above [24] three. Therefore, clinical formulations,various stimuli NC-6300-respon- thatsive isPASPAm an epirubicin derivatives (EPI) conjugatedsuch as NC PEG-block-PASPAm-6300 have been designed derived and copolymer synthesized containing over the acid-labilelast decades, hydrazone and their linkages,potentialis applications the only one in with different stimuli-responsiveness. fields were also investigated Results showed exten- thatsively. NC-6300 In this exhibitedreview, PASPAm a stronger derivatives anti-tumor are effect defined and as lower polymers cardiotoxicity composed compared wholly toor freepartly EPI, of whichaspartamide may be units due toas itsshown pH responsiveness.in Figure 1. FigureFigure 1. The synthetic pathways of PA PASPAm-basedSPAm-based ((aa)) graftgraft copolymerscopolymers andand ((bb)) blockblock copolymers.copolymers. BecauseAlthough stimuli-responsive some papers have polymersreviewed canthe synthesis respond toand the applications changes of of environmental poly(aspartic factorsacid) (PASP) (e.g., [25] pH, and temperature) PSI [26] derivatives, by self-changing there is eitherno comprehensive their physical review properties, summarizing chem- icalthe recent structures, progress or both,of “stimuli they-responsive exhibit attractive PASPAm prospects derivatives”. in a varietyIn this paper, of fields we will such pro- as sensors,vide an overview energy conversion of the up-to and-date drug/gene developments delivery on stimuli systems-responsive [24]. Therefore, PASPAm various deriva- stimuli-responsivetives and their applications PASPAm as derivativesdrug carriers. such First, as the NC-6300 synthesis have strat beenegies designed of stimuli and-respon- syn- thesizedsive PASPAm over thederivatives last decades, will be and reviewed their potential by the type applications of triggers. in Next, different the applications fields were alsoof stimuli investigated-responsive extensively. PASPAm In derivatives this review, for PASPAm drug delivery derivatives will are be definedintroduced. as polymers Finally, composedthe further whollyperspectives or partly of stimuli of aspartamide-responsive units PASPAm as shown de inrivatives Figure 1will. be discussed. Although some papers have reviewed the synthesis and applications of poly(aspartic acid) (PASP) [25] and PSI [26] derivatives, there is no comprehensive review summariz- ing the recent progress of “stimuli-responsive PASPAm derivatives”. In this paper, we will provide an overview of the up-to-date developments on stimuli-responsive PAS- PAm derivatives and their applications as drug carriers. First, the synthesis strategies of stimuli-responsive PASPAm derivatives will be reviewed by the type of triggers. Next, the applications of stimuli-responsive PASPAm derivatives for drug delivery will be in- Int. J. Mol. Sci. 2021, 22, 8817 3 of 18 troduced. Finally, the further perspectives of stimuli-responsive PASPAm derivatives will be discussed. 2. Synthesis 2.1. Temperature-Responsive Poly(aspartamide) Derivatives Temperature is an important stimulus for stimuli-responsive polymers. Poly(N- isopropylacrylamide) (PNIPAAm) is one of the most investigated temperature-responsive polymers with a lower critical solution temperature (LCST) at around 32 ◦C. As is well known, the temperature-responsive behavior of PNIPAAm is ascribed to its N-isopropylamide pendants. Therefore, N-isopropylamide and various functional groups with similar struc- tures were introduced for preparing temperature-responsive